{"id":408345,"date":"2019-07-11T12:10:01","date_gmt":"2019-07-11T12:10:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=408345"},"modified":"2019-07-11T12:10:01","modified_gmt":"2019-07-11T12:10:01","slug":"q-fever-industry-treatment-outlook-analysis-research-review-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/q-fever-industry-treatment-outlook-analysis-research-review-to-2023_408345.html","title":{"rendered":"Q Fever Industry \u2013 Treatment, Outlook, Analysis, Research, Review to 2023"},"content":{"rendered":"
\"Q<\/a><\/p>\n
\n
Q Fever Market<\/div>\n<\/div>\n<\/div>\n
WiseGuyReports.Com Publish a New Market Research Report On \u2013\u201c Q Fever Industry \u2013 Treatment, Outlook, Analysis, Research, Review to 2023\u201d.<\/div>\n

 <\/p>\n

Q Fever Industry 2019<\/strong><\/a><\/p>\n

Description<\/strong>:-<\/p>\n

Q fever<\/strong> is a mild disease with flu-like symptoms. In Q fever, the infection is caused by the bacterium Coxiella burnetii. Many patients have no symptoms at all, while, in some cases, the infection could reoccur\/resurface years later. Chronic Q fever may damage the heart, liver, brain, lungs, and could cause diabetes in some cases.
The major factors driving the growth of the market include rising prevalence of Q fever coupled with increasing Q fever hospitalization rates, rising worldwide cattle, sheep, and goat population, growth in risk factors of Q fever, and globally growing geriatric population. <\/p>\n

 <\/p>\n

Get a Free Sample Report<\/strong>@<\/em><\/strong>  https:\/\/www.wiseguyreports.com\/sample-request\/4255640-global-q-fever-market-research-report-forecast-to-2023<\/a><\/p>\n

For more information or any query mail at sales@wiseguyreports.com<\/em><\/strong><\/p>\n

 <\/strong><\/p>\n

The global Q fever market has been segmented on the basis of type, diagnosis, treatment, end user, and region. 
The global Q fever market, by type, has been segmented into acute and chronic. 
The global Q fever market, by diagnosis, has been segmented into serology tests and others. 
The global Q fever market, by treatment, has been segmented into antibiotics and surgery. 
The global Q fever market, by end user, has been segmented into patients, hospitals and clinics, and others. 
The global Q fever market is expected to reach a market value of USD 9,850.65 million by 2023 from USD 6,249.68 million in 2017 and is expected to register a CAGR of 7.83% during the forecast period of 2018 to 2023. In 2017, Asia-Pacific held the highest share of the market at 44.9%, followed by the Middle East and Africa with a share of 25.4%.<\/p>\n

Key Players 
<\/strong>Merck KGaA, Teva Pharmaceutical Industries Ltd, Pfizer Inc., Basilea Pharmaceutica Ltd, Sanofi S. A., Melinta Therapeutics, Inc., Bayer AG, Johnson & Johnson Services, Inc., Yashica Pharmaceuticals, and AtoxBio. <\/p>\n

Study Objectives 
<\/strong>• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the Q fever market 
• To provide insights into factors affecting the market growth 
• To analyze the global Q fever market based on various tools such as supply chain analysis and Porter’s five force analysis 
• To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries 
• To provide country-level analysis of the market with respect to the current market size and future perspective 
• To provide country-level analysis of the market for segments by type, diagnosis, treatment, end user, and region 
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies and drawing a competitive landscape for the market 
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Q fever market <\/p>\n

Target Audience 
<\/strong>• Hospitals 
• Q fever Companies 
• Associations and Organizations <\/p>\n

 <\/p>\n

Ask Query @<\/em><\/strong>  https:\/\/www.wiseguyreports.com\/enquiry\/4255640-global-q-fever-market-research-report-forecast-to-2023<\/a><\/p>\n

 <\/p>\n

Key Findings 
<\/strong>• The global Q fever market is expected to reach USD 9,850.65 million by 2023 at a CAGR of 7.83% from 2018 to 2023 
• On the basis of type, the chronic segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 7.33% during the forecast period 
• On the basis of diagnosis, the serology tests segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 8.32% during the forecast period 
• On the basis of treatment, the antibiotics segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 7.32% during the forecast period 
• On the basis of end user, the patients segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 8.21% during the forecast period <\/p>\n

Regional Analysis 
<\/strong>• Americas 
o North America 
§ US 
§ Canada 
o Latin America 
• Europe 
o Germany 
o France 
o UK 
o Italy 
o Spain 
o Rest of Europe 
• Asia-Pacific 
o Japan 
o China 
o India 
o Australia 
o Republic of Korea 
o Rest of Asia-Pacific 
• Middle East & Africa 
o UAE 
o Saudi Arabia 
o Oman 
o Kuwait 
o Qatar 
o Africa 
o Rest of the Middle East & Africa<\/p>\n

Table Of Content – Major key Points<\/strong><\/p>\n

1 Report prologue <\/strong><\/p>\n

2 Market Introduction<\/strong><\/p>\n

3 Research Methodology <\/strong><\/p>\n

4 Market Dynamics <\/strong><\/p>\n

5 Market Factor Analysis <\/strong><\/p>\n

6 Global Q Fever Market, By Type <\/strong><\/p>\n

7 Global Q Fever Market, By Diagnosis <\/strong><\/p>\n

8 Global Q Fever Market, By Treatment <\/strong><\/p>\n

9 Global Q Fever Market, By End-User   <\/strong><\/p>\n

Continued……<\/strong><\/p>\n

ABOUT US: <\/strong><\/p>\n

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd<\/strong>. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com<\/a>
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Q Fever Market WiseGuyReports.Com Publish a New Market Research Report On \u2013\u201c Q Fever Industry \u2013 Treatment, Outlook, Analysis, Research, Review to 2023\u201d.   Q Fever Industry 2019 Description:- Q fever is a mild disease with flu-like symptoms. In Q … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,420,416],"tags":[],"class_list":["post-408345","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/408345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=408345"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/408345\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=408345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=408345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=408345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}